Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre V Ivachtchenko

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Medicinal Chemistry|February 22, 2011
2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Journal of Combinatorial Chemistry|July 11, 2006
Liquid-phase parallel synthesis of combinatorial libraries of substituted 6-carbamoyl-3,4-dihydro-2H-benzo[1,4]thiazinesAndrey S Trifilenkov, Vladimir V Kobak, Marina A Salina, et al.
Journal of Combinatorial Chemistry|March 15, 2005
Parallel liquid-phase synthesis of N-substituted 6-aminosulfonyl-2-oxo-1,2-dihydroquinoline-4-carboxamide and 6-aminosulfonylquinoline-4-carboxamide derivativesAlexandre V Ivachtchenko, Vladimir V Kobak, Alexey P Ilyn, et al.
The Journal of Organic Chemistry|March 25, 2006
One-step assembly of carbamoyl-substituted heteroannelated [1,4]thiazepinesAlexey P Ilyn, Marina V Loseva, Vladimir Y Vvedensky, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
CNS Spectrums|June 18, 2013
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot studyMargarita A Morozova, Taisiya A Lepilkina, Georgy E Rupchev, et al.
Antiviral Research|August 11, 2023
Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B virusesAndrei A Ivashchenko, Jeremy C Jones, Dmitry O Shkil, et al.
Heliyon|December 18, 2019
Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylateAlexandre V Ivachtchenko, Oleg D Mitkin, Dmitry V Kravchenko, et al.
Journal of Combinatorial Chemistry|March 31, 2010
Solution phase parallel synthesis of substituted 3-phenylsulfonyl-[1,2,3]triazolo[1,5-a]quinazolines: selective serotonin 5-HT(6) receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Molecules (Basel, Switzerland)|September 19, 2020
Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking StudiesSergiy M Kovalenko, Oleksandr G Drushlyak, Svitlana V Shishkina, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|February 22, 2011
2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Journal of Combinatorial Chemistry|July 11, 2006
Liquid-phase parallel synthesis of combinatorial libraries of substituted 6-carbamoyl-3,4-dihydro-2H-benzo[1,4]thiazinesAndrey S Trifilenkov, Vladimir V Kobak, Marina A Salina, et al.
Journal of Combinatorial Chemistry|March 15, 2005
Parallel liquid-phase synthesis of N-substituted 6-aminosulfonyl-2-oxo-1,2-dihydroquinoline-4-carboxamide and 6-aminosulfonylquinoline-4-carboxamide derivativesAlexandre V Ivachtchenko, Vladimir V Kobak, Alexey P Ilyn, et al.
The Journal of Organic Chemistry|March 25, 2006
One-step assembly of carbamoyl-substituted heteroannelated [1,4]thiazepinesAlexey P Ilyn, Marina V Loseva, Vladimir Y Vvedensky, et al.
Molecules (Basel, Switzerland)|August 12, 2022
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2Andrey A Ivashchenko, Bogdan A Zagribelnyy, Yan A Ivanenkov, et al.
CNS Spectrums|June 18, 2013
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot studyMargarita A Morozova, Taisiya A Lepilkina, Georgy E Rupchev, et al.
Antiviral Research|August 11, 2023
Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B virusesAndrei A Ivashchenko, Jeremy C Jones, Dmitry O Shkil, et al.
Heliyon|December 18, 2019
Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylateAlexandre V Ivachtchenko, Oleg D Mitkin, Dmitry V Kravchenko, et al.
Journal of Combinatorial Chemistry|March 31, 2010
Solution phase parallel synthesis of substituted 3-phenylsulfonyl-[1,2,3]triazolo[1,5-a]quinazolines: selective serotonin 5-HT(6) receptor antagonistsAlexandre V Ivachtchenko, Elena S Golovina, Madina G Kadieva, et al.
Molecules (Basel, Switzerland)|September 19, 2020
Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking StudiesSergiy M Kovalenko, Oleksandr G Drushlyak, Svitlana V Shishkina, et al.
Pageof 7